Navigation Links
Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
Date:7/28/2009

ger described herein, TorreyPines expects to file a registration statement on Form S-4, which shall include a joint proxy statement/prospectus, with the U.S. Securities Exchange Commission ("SEC") and any other necessary regulatory filings. Depending on the review process of the regulatory agencies, the companies currently expect the merger to close in the fourth quarter of 2009. Upon closing the transaction, the combined company's shares are expected to trade on the Nasdaq Capital Market. TorreyPines is advised by Merriman Curhan Ford and Raptor is advised by Beal Advisors.

The combined company will be dedicated to addressing unmet medical needs and underserved patient populations, by developing new or improving existing treatments, through enhanced drug targeting or reformulation of existing therapeutic compounds.

Management and Organization

Following the closing, the combined company will have offices in Novato, California. Executive management will be as follows:

  • Christopher M. Starr, Ph.D., Chief Executive Officer
  • Ted Daley, President
  • Patrice Rioux, M.D., Ph.D., Chief Medical Officer
  • Todd C. Zankel, Ph.D., Chief Scientific Officer
  • Kim R. Tsuchimoto, C.P.A., Chief Financial Officer

Investors and security holders of Raptor and TorreyPines are urged to read the joint proxy statement/prospectus to be included in a registration statement filed on Form S-4 (including any amendments or supplements thereto) regarding the merger when it becomes available because it will contain important information about Raptor and TorreyPines. Raptor's and TorreyPines' stockholders will be able to obtain a copy of the joint proxy statement/prospectus, as well as other filings containing information about Raptor and TorreyPines, without charge, at the SEC's Internet website (

SOURCE Raptor Pharmaceuticals Corp.; TorreyPines Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Raptor Pharmaceuticals Corp. to Present at 2009 Cystinosis Research Network Family Conference
2. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
3. Smith & Nephew Endoscopys OSTEORAPTOR(TM) Anchor Provides Bioabsorbable Solution for Labral Tears in the Hip and Shoulder
4. Raptor Pharmaceuticals Corp. to Present at Two Upcoming Healthcare Conferences
5. Glendale Raptors Join Four Points by Sheraton Denver Southeast and Animal Planets Dr. Kevin Fitzgerald for Second Annual Halloween Costume Drive & Halloween Party for Kunsberg School at National Jewish Medical and Research Center
6. The Glendale Raptors Set Dates for Youth Rugby League and USA Rugby Youth Academy
7. Smith & Nephew Endoscopys BIORAPTOR(TM) 2.3 PK Suture Anchor Provides Secure Repair for Shoulder, Hip Instability
8. Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp.
9. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
10. Millennium Pharmaceuticals Inc./Lymphoma Research Foundation funds lymphoma research
11. Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... Coffee could not only perk you up in the morning ... have found. , They found that those who drank coffee ... fight gum disease. Does coffee, then, help fight gum disease? ... Goldman School of Dental Medicine explored in a study ... of Periodontology. , “This is the first long-term study of ...
(Date:3/28/2015)... "Necrorun" was featured on NewsWatch as part of ... latest and coolest applications on the market for iOS, ... and technology expert, conducted the app review and shared ... game with knights, nature, and peasants. , The ... to Eurogamer. The popularity of these games grew over ...
(Date:3/28/2015)... With more than 4,500 scientists, ... osteoporosis, osteoarthritis and musculoskeletal diseases gathered here for ... the first time in the 17-year history of ... hot-button topic is an emerging non-pharmaceutical protocol for ... principles of Wolff’s law, osteogenic loading at multiples ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 The California-based ... package for every customer shopping on UniWigs during the ... also be a big promotion on April Fools’ Day. ... Day is just around the corner. Easter Festival, with ... States, is a major holiday after Christmas. The best ...
(Date:3/28/2015)... March 28, 2015 India Network ... is made available to all visitors who purchase the ... All members are encouraged to purchase the insurance program ... lack of proper coverage for pre-existing medical conditions. Parents ... or two medical conditions with serious consequences to their ...
Breaking Medicine News(10 mins):Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3
... being diagnosed with testicular cancer, according to a study ... second major study in less than four months to ... cancer of the testicles. ,But the researchers maintain ... with abnormal semen characteristics" for the absolute increase in ...
... which has already been shown to help prevent heart ... and other types of dementia.// The study also found ... - the effect is the same. Researchers say moderate ... may protect against dementia. ,The adverse effect of ...
... found that errors in the alpha gene are the cause ... ovarian failure.It affects about 2% of the total population.// ... to the development of a genetic test, which would allow ... if they are at risk. They analysed DNA from women ...
... the diet does not help prevent the return of kidney ... oxalate and one approach to preventing this painful condition// is ... since calcium is important for keeping a healthy level of ... good evidence for its role in protection against kidney stones. ...
... vitamin A may increase the risk of hip fractures in ... healthy skin and hair and bone growth.// Researchers found that ... and vitamin supplements - had double the risk of hip ... ,One theory is that too much vitamin A inhibits the ...
... appropriate treatment should be recommended for paitents with breast ... have// had breast cancer do well years after treatment, ... reduced physical functioning. Researchers at the University of Cleavland ... quality of life in long-term survivors of breast cancer. ...
Cached Medicine News:
(Date:3/27/2015)... March 27, 2015 XRpro Sciences, Inc., ... discovery and development services which features high throughput ... industry, announced financial results for the year ended ...  Tyson, Chairman of XRpro Sciences commented, "We have ... from development stage to commercial stage in large ...
(Date:3/27/2015)... , March 27, 2015 According ... Product (Diagnostic Catheter (Conventional, Advanced, Ultrasound), Ablation Catheter (Cryoablation, ... & Indication (AF, VT, WPW) - Global Forecasts to ... expected to reach around ~$4.73 Billion by 2019 with ... 2014 to 2019. Browse   90 ...
(Date:3/27/2015)... March 27, 2015  RXi Pharmaceuticals Corporation ... LLC, today announced that they have entered ... novel and proprietary sd-rxRNA® technology for use ... collaboration has the potential to result in ... treatments that could be a significant step ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
... Instrumentation Laboratory (IL) today announced the appointment of ... May 1, 2011.  Mr. Benet began his career with ... President of Worldwide Marketing, Sales and Service.   ... Manent who served as CEO since 1999.  Under Mr. ...
... NxStage Medical, Inc. (Nasdaq: NXTM ), a ... Michael Miller, Jr., former Senior Vice President and General ... has joined the NxStage senior management team in the ... be responsible for advancing the Company,s international growth plans ...
Cached Medicine Technology:Instrumentation Laboratory Appoints Ramon E. Benet New Chief Executive Officer 2NxStage® Names Michael Miller, Jr. President, International 2NxStage® Names Michael Miller, Jr. President, International 3
This set is designed to introduce the low vision practitioner to the Keeler telescopic system....
... up to 20 tilting ... in the vertical, horizontal ... the option to offset ... transillumination., ,Filters include Cobalt ...
An easy to use uncomplicated ophthalmoscope....
With a high lens and filter range this ophthalmoscope is ideal for the Primary Care Specialist...
Medicine Products: